| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |